Speak Out Rheum

Risks and Benefits

David S. Pisetsky, MD, PhD | September 1, 2009

Physicians must find the delicate balance between treatment and side effects

David S. Pisetsky, MD, PhD | August 1, 2009

EULAR captured the complex picture of rheumatology’s future

David S. Pisetsky, MD, PhD | July 1, 2009

Pondering drug safety

David S. Pisetsky, MD, PhD | June 1, 2009

Physicians must remember that all drugs have safety risks

David S. Pisetsky, MD, PhD | May 1, 2009

Finding cost-effective solutions in the quest for personalized medicine

David S. Pisetsky, MD, PhD | April 1, 2009

Campaign figure’s connection to personalized medicine

David S. Pisetsky, MD, PhD | March 1, 2009

Will an election driven by change bring agreeable—and affordable—healthcare reform?

David S. Pisetsky, MD, PhD | February 1, 2009

May 2009 bring us a return to constructive, thoughtful oversight in all fields

David S. Pisetsky, MD, PhD | January 1, 2009

The fortunes of industry and academia may rise and fall together

David S. Pisetsky, MD, PhD | December 1, 2008

Anticipation—both bad and good—was the mood at this year’s ACR meeting